XNASCYRX
Market cap363mUSD
Jan 15, Last price
7.35USD
1D
-1.87%
1Q
3.09%
Jan 2017
126.85%
IPO
178.99%
Name
Cryoport Inc
Chart & Performance
P/E
—
P/S
1.56
EPS
—
Div Yield, %
2.20%
Shrs. gr., 5y
11.56%
Rev. gr., 5y
64.06%
Revenues
233m
-1.70%
Net income
-100m
L+166.75%
CFO
-757k
L-59.10%
Earnings
Mar 10, 2025
Profile
Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle. It also provides information dashboards and validation documentation for shipments through data collected by the SmartPak Condition Monitoring System; and vacuum insulated aluminum dewars and cryogenic freezers systems. In addition, the company offers biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; transportation of frozen biological specimens to and from customer locations; and management of incoming and outgoing biological specimens, as well as provides logistics support and management; and short-term logistics and engineering consulting services. It serves biopharma/pharma, animal health, and human reproductive medicine markets. The company was founded in 1999 and is headquartered in Brentwood, Tennessee.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2016‑03 | 2015‑03 | |
| Income | ||||||||||
Revenues | 233,255 -1.70% | 237,277 6.59% | ||||||||
Cost of revenue | 168,250 | 149,126 | ||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 65,005 | 88,151 | ||||||||
NOPBT Margin | 27.87% | 37.15% | ||||||||
Operating Taxes | 239 | 2,239 | ||||||||
Tax Rate | 0.37% | 2.54% | ||||||||
NOPAT | 64,766 | 85,912 | ||||||||
Net income | (99,587) 166.75% | (37,333) -86.45% | ||||||||
Dividends | (8,000) | (8,000) | ||||||||
Dividend yield | 1.06% | 0.94% | ||||||||
Proceeds from repurchase of equity | 1,478 | (35,912) | ||||||||
BB yield | -0.20% | 4.23% | ||||||||
| Debt | ||||||||||
Debt current | 5,806 | 3,908 | ||||||||
Long-term debt | 410,197 | 460,717 | ||||||||
Deferred revenue | 30,309 | |||||||||
Other long-term liabilities | 10,098 | 5,128 | ||||||||
Net debt | (40,752) | (58,698) | ||||||||
| Cash flow | ||||||||||
Cash from operating activities | (757) | (1,851) | ||||||||
CAPEX | (44,900) | (24,197) | ||||||||
Cash from investing activities | 36,045 | (59,681) | ||||||||
Cash from financing activities | (23,798) | (39,174) | ||||||||
FCF | 43,092 | 46,901 | ||||||||
| Balance | ||||||||||
Cash | 456,755 | 523,323 | ||||||||
Long term investments | ||||||||||
Excess cash | 445,092 | 511,459 | ||||||||
Stockholders' equity | (642,160) | (559,058) | ||||||||
Invested Capital | 1,557,284 | 1,555,932 | ||||||||
ROIC | 4.16% | 5.57% | ||||||||
ROCE | 7.08% | 8.80% | ||||||||
| EV | ||||||||||
Common stock shares outstanding | 48,737 | 48,987 | ||||||||
Price | 15.49 -10.72% | 17.35 -70.68% | ||||||||
Market cap | 754,942 -11.18% | 849,930 -68.72% | ||||||||
EV | 740,465 | 809,507 | ||||||||
EBITDA | 92,492 | 110,916 | ||||||||
EV/EBITDA | 8.01 | 7.30 | ||||||||
Interest | 5,503 | 6,142 | ||||||||
Interest/NOPBT | 8.47% | 6.97% | ||||||||